Literature DB >> 8131790

Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae.

M Leinonen1.   

Abstract

The antibody prevalence data indicate that C. pneumoniae infections are common worldwide and more frequently occur in middle-aged and elderly males than in females. C. pneumoniae infections are first acquired in childhood in heavily populated areas, whereas in northern countries, first infections are generally at teenage and in Scandinavia, typically at the time of military service. All chlamydial species tend to cause chronic infections, with severe sequelae developing 10 to 50 years after the primary infections. If C. pneumoniae resides in alveolar macrophages or in vascular endothelial cells in chronic infections the bacteria and their structural components, such as lipopolysaccharides have an easy access to circulation. The continuous induction of cytokines by C. pneumoniae may lead to chronic inflammation of vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131790

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

2.  Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain.

Authors:  E James Arking; Denah M Appelt; J Todd Abrams; Sonya Kolbe; Alan P Hudson; Brian J Balin
Journal:  Pathogenesis (Amst)       Date:  1999

3.  Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Authors:  J T Abrams; E C Vonderheid; S Kolbe; D M Appelt; E J Arking; B J Balin
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 4.  Asthma in children: are chlamydia or mycoplasma involved?

Authors:  S Esposito; N Principi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

Authors:  C Scott Little; Andrew Bowe; Richard Lin; Jason Litsky; Robert M Fogel; Brian J Balin; Kerin L Fresa-Dillon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?

Authors:  John D Carter; Hervé C Gérard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2011-06

7.  Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.

Authors:  Ute Dreses-Werringloer; Mohammad Bhuiyan; Yinghao Zhao; Hervé C Gérard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Med Microbiol       Date:  2008-09-30       Impact factor: 3.473

8.  Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function.

Authors:  Thorarinn Gislason; Vilmundur Guðdnason; Bryndis Benediktsdottir; Isleifur Olafsson; Thor Aspelund; Bjarni Thjodleifsson; Christer Janson
Journal:  BMC Pulm Med       Date:  2010-08-25       Impact factor: 3.317

9.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01

10.  Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.

Authors:  Corinna Hermann; Katja Gueinzius; Albrecht Oehme; Sonja Von Aulock; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.